Lilly took a sharp tone in responding to a New York Times article that the company said "likely created a strong false impression with readers that Lilly suppresses data."

Wyeth hired Timothy Cost to head its corporate affairs department, replacing Marily Rhudy, who is retiring.

When choosing a celebrity product spokesperson in the scrutinized world of pharmaceutical communications, it's essential that great care and consideration is put into the selection.

It's a reflection of our times: if you're in healthcare you must also have political smarts.

Two top pharmas looked outside the industry for their top communications executives

Bowing to outraged patient advocates, NYU Child Study Center said it will halt its controversial print and outdoor ads aimed at raising awareness of mental health problems in kids.

The consumer has arrived in health.

Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, generated some unwelcome publicity when he lashed out at a 17-year-old intern from a Savannah, GA, newspaper at a November event for the patient assistance program.

MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.

Treating rare disorders was once considered a "good-will science endeavor," but market forces have encouraged companies to revisit how these small molecules can be big business, and researchers are finding that therapeutic applications for one rare disease area often holds promise in others.